Allogeneic hematopoietic cell transplantation: the state of the art - Wikidata - awgldk - TriplyDB

Allogeneic hematopoietic cell transplantation: the state of the art

Allogeneic hematopoietic cell transplantation: the state of the art

http://www.wikidata.org/entity/Q34145155

about

Non-embryo-destructive Extraction of Pluripotent Embryonic Stem Cells: Implications for Regenerative Medicine and Reproductive Medicine Desensitization for solid organ and hematopoietic stem cell transplantation Delivering care to long-term adult survivors of hematopoietic cell transplantation.Hematopoietic Stem Cells in Regenerative Medicine: Astray or on the Path?Acellular bone marrow extracts significantly enhance engraftment levels of human hematopoietic stem cells in mouse xeno-transplantation models Busulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthase The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor, or haploidentical family donor in patients with leukemia: a retrospective analysis of data from the China RIC Cooperative Grou Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation.Cord blood banking - bio-objects on the borderlands between community and immunity.Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.Chimeric Antigen Receptor T-Cell Therapy for the Community Oncologist A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.Notch signaling in hematopoietic cell transplantation and T cell alloimmunity.Validation of the EBMT Risk Score for South Brazilian Patients Submitted to Allogeneic Hematopoietic Stem Cell Transplantation.Zebularine significantly sensitises MEC1 cells to external irradiation and radiopharmaceutical therapy when administered sequentially in vitro.Emerging concepts in haematopoietic cell transplantation.Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation.Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications.Blood stem cell products: toward sustainable benchmarks for clinical translation.Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.Complications of allogeneic hematopoietic stem cell transplantation.MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.Patients' experiences of different care settings and a new life situation after allogeneic haematopoietic stem cell transplantation.Treg therapy in transplantation: a general overview.Family members' life situation and experiences of different caring organisations during allogeneic haematopoietic stem cells transplantation-A qualitative study.Microbiota: a key orchestrator of cancer therapy.Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031).The use of donor-derived veto cells in hematopoietic stem cell transplantation.Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma.Ex vivo expanded hematopoietic stem cells overcome the MHC barrier in allogeneic transplantation.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Effects of exercise interventions in graft-versus-host disease models.Assessing the HLA diversity of cord blood units collected from a birth clinic caring for pregnant women in an ethnically diverse metropolitan area.Protein dysregulation in graft versus host disease.First Successful Haploidentical Stem Cell Transplantation in Romania.Outcomes of adults with active or progressive hematological malignancies at the time of allo-SCT: a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Therapeutic efficiency of platelet gel for the treatment of oral ulcers related to chronic graft versus host disease after allogeneic haematopoietic stem cell transplantation.

P2860

Q26771342-4163A08A-F124-4A9B-B81A-F7C56C9AE554 Q26863564-B62E2BC5-5695-4DC8-85E3-9413D39D7AFC Q27021501-C488BB61-467C-4BED-86D2-EBD1AB86C950 Q28072887-2E8C14ED-7DB3-4DF1-A7E9-246780101F1C Q28727639-5088ABF6-714D-4A4F-A3E1-D11970E78DC0 Q28732371-5DA8152C-DDAC-430D-9366-4B610F8581A1 Q31143348-E5693BD9-1739-4AF9-8604-C9CFAC231E64 Q33755190-FF108057-1AD2-4B69-9957-1C6C603279AF Q35778492-87D3CC62-5855-4DD7-B32B-27BD6BB98128 Q36137737-3DFE9405-84C8-414A-AC84-8A849E45CF56 Q36579263-50A3EA15-3B1B-444B-AB73-3C0127F1A10C Q36583196-42218FAA-13CB-43A3-87CA-6048988387F5 Q36884399-AD7E0F9A-F94B-47D4-BFDB-BC6035600FDB Q36903202-903274AB-A54F-498B-BE53-CA172F0B1896 Q37060673-4B229BD1-AC8B-44EE-ACC3-506CAE7FB170 Q37325713-E2ADBD8E-9EE9-4E30-9FF1-83A2BBDA8A50 Q37422385-1A7CB9D2-6FB8-4C8E-AE1E-13B5A6633E99 Q37625716-ADE30A5E-98F5-4F55-AA9F-5178E692DF9D Q38013047-C90A744F-1304-47B8-B7D3-F653A3EAEAA7 Q38035452-F1DC46B1-F911-4C38-9159-867061C01BDD Q38048723-1EA33670-9059-44F0-BC6C-67F2A7754DAD Q38072649-2D2851F4-7AB4-41BF-A304-44FB10EBE9B5 Q38088242-B1A57E91-0AF7-426A-9F3F-BDEE8DAB3C37 Q38217938-4260FEDF-62A3-40F1-A689-AA7E605E05F8 Q38434710-6EB63A75-1EFD-44B9-B4B1-6AA02C0C7219 Q38751585-9806F577-4D56-4AF6-B7C8-BAD6BB1661EB Q38778543-1BCD6FBE-D403-42D4-84E2-5AE3C0EAAD14 Q39176991-B3AC06BD-68FE-4CE1-94B0-FD4621D6762D Q39183428-D3816A99-B9F6-4A1B-B4DE-E67EE820C865 Q41337245-C75B3CA4-E644-451C-BC3C-FB465BB7FE15 Q42144054-D1D70C7D-019B-4A24-B17C-6B39079455B7 Q42214758-3B3C4549-2DDD-4AD3-AF52-6E076A7853B6 Q42226969-FD230E34-8541-4C70-A254-4F59ED98A11C Q43988469-7985FB31-98EA-449C-9CAE-D4D441DF89DC Q45324881-AD39C094-3122-43F6-8F8E-1B966395956F Q46191094-A9DFA667-8640-4968-BF85-40CEC33289C2 Q49228781-C4EBE08B-6772-4AA5-8E9D-9E1ED3121E5B Q51798540-5B71D777-1ADE-446C-B5CA-5A51072262C8 Q54509279-27EBA382-2869-43F2-86F3-03B3B45E1B3D Q55183614-70B2761B-5AC1-435E-952B-86FB1DBFD858

P2860

Allogeneic hematopoietic cell transplantation: the state of the art

http://www.wikidata.org/entity/Q34145155

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Allogeneic hematopoietic cell transplantation: the state of the art

@ast

Allogeneic hematopoietic cell transplantation: the state of the art

@en

Allogeneic hematopoietic cell transplantation: the state of the art

@nl

type

label

Allogeneic hematopoietic cell transplantation: the state of the art

@ast

Allogeneic hematopoietic cell transplantation: the state of the art

@en

Allogeneic hematopoietic cell transplantation: the state of the art

@nl

prefLabel

Allogeneic hematopoietic cell transplantation: the state of the art

@ast

Allogeneic hematopoietic cell transplantation: the state of the art

@en

Allogeneic hematopoietic cell transplantation: the state of the art

@nl

P1433

Q34145155-EFE41046-B502-4558-BCB5-3686CF529CBC

P1476

Q34145155-5E566892-C787-4590-A056-8FEC398876D4

P2093

Q34145155-6E9DA65B-4B71-490F-8118-3DFD0DA1B0CE

Q34145155-DDE71E86-CFA8-4A80-A9A8-F996036AE086

P2860

Q34145155-004ECC61-80CE-41F1-B98F-1ED4EEB67759

Q34145155-017C5549-7627-43B4-932B-AB0B38548337

Q34145155-0866D3CB-B2F3-459F-822E-6F84D827C8EE

Q34145155-09424477-74F8-46D5-B247-66E5E6F07B2D

Q34145155-0EDEABB6-E35D-4789-9B92-28BB81837DF8

Q34145155-12DFFBA6-D939-486A-84F8-7800992584B0

Q34145155-1431F9A0-E007-4818-BB4E-C32D750BC946

Q34145155-181FA08F-C2EB-4697-9095-9A9677E8A557

Q34145155-1D606E5B-1EA5-4A27-8BCC-6455940E3BB5

Q34145155-1FFFCC85-7AAF-44D4-81EF-FB6EAF84A84E

P304

Q34145155-99FB9A1B-59D9-4A29-8BE8-A472BA8CC562

P31

Q34145155-06BE335B-0B3D-463C-912F-45B5A06B8AD0

P356

Q34145155-2C2EE748-2116-4F26-AF8D-97547CC02F79

P433

Q34145155-D58F62A3-C501-40A5-8A54-7493D5A945B7

P478

Q34145155-D140F222-2F70-4D4B-B1C7-AB87DB726374

P50

Q34145155-C9ECBA71-4F3D-4CC8-9CC3-73A296696BAC

P577

Q34145155-B71EC57A-BEFB-4D8B-BEF5-8DBAC82FFBE5

P5875

Q34145155-BAA546EF-A1CC-4D8A-9E92-2383209E725C

P698

Q34145155-536F6FE5-DB32-4490-9CC2-713012E46576

P932

Q34145155-5AFB9393-9C41-43BE-BB10-61CFAABF91D5

P356

P1433

Expert Review of Hematology

P1476

Allogeneic hematopoietic cell transplantation: the state of the art

@en

P2093

Andrew Rezvani

http://www.w3.org/2001/XMLSchema#string

Boglarka Gyurkocza

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials.

Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation.

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.

Unrelated marrow transplantation for adult patients with poor-risk acute lymphoblastic leukemia: strong graft-versus-leukemia effect and risk factors determining outcome.

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.

P304

285-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/EHM.10.21

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Rainer F. Storb

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46428150

http://www.w3.org/2001/XMLSchema#string

P698

20871781

http://www.w3.org/2001/XMLSchema#string

P932

2943393

http://www.w3.org/2001/XMLSchema#string